NHẬN XÉT ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG CỦA BỆNH NHÂN UNG THƯ DẠ DÀY ĐIỀU TRỊ BỔ TRỢ PHÁC ĐỒ CAPEOX TẠI BỆNH VIỆN QUÂN Y 103 VÀ BỆNH VIỆN BẠCH MAI

Abstract

Objective: Describe clinical and subclinical characteristics of gastric cancer patients who received CapeOx adjuvant regimen at 103 military hospital and Bach Mai hospital from 2018-2020. Subjects: 40 gastric cancer patients who received CapeOx adjuvant regimen at the Military hospital 103 and Bach Mai hospital from 2018-2020. Research indexes include age, sex, history of gastric diseases, clinical symptoms, preoperative CA72-4 concentration, time of diagnosis, site of tumor, type of histopathology, stage of disease. Methods: Cross-sectional study. Results: The median age of 40 patients was 57.4 ± 10.4, male/female ratio was 3.44/1. Clinical symptoms varied and nonspecific, of which the most common symptom was epigastric abdominal pain, accounting for 92.5%, it is also the main reason of patients to take health check; 45% of patients had no previous history of gastric diseases. Lesion sites were mainly found in the pyloric region (60%) and lesser curvature of the gastric (32.5%). The poorly differentiated subtype had the highest percentage (45%). Stage IIA and IIIA were the most popular, each stage accounted for 27.5% the number of patients with stage IB-IIA is higher than that of stage IIIB-IIIC. Conclusion: The clinical and subclinical features of gastric cancer patients who received CapeOx adjuvant regimen at 103 military hospital and Bach Mai hospital from 2018-2020, were quite similar to previous studies.